Learn more about a new cancer blood test that increases cancer detection multifold and what its limitations are.
The PCR-based point-of-care test runs on the Cobas Liat platform and returns results for three Bordetella species in 15 minutes.
The blood-based test is intended to aid in the decision for prostate biopsy for men older than 50 with elevated PSA levels.